These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 9453831)
1. [Behavioral and neurochemical methods in research on new psychotropic drugs]. Boulu R Bull Acad Natl Med; 1997; 181(6):1047-56. PubMed ID: 9453831 [TBL] [Abstract][Full Text] [Related]
2. [Behavioral and neurochemical methods in research on new psychotropics]. Boulu R Ann Pharm Fr; 1998; 56(2):54-9. PubMed ID: 9770024 [TBL] [Abstract][Full Text] [Related]
3. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. Baghdadli A; Gonnier V; Aussilloux C Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786 [TBL] [Abstract][Full Text] [Related]
4. [Acting out and psychoactive substances: alcohol, drugs, illicit substances]. Gillet C; Polard E; Mauduit N; Allain H Encephale; 2001; 27(4):351-9. PubMed ID: 11686057 [TBL] [Abstract][Full Text] [Related]
5. [Psychotropic drugs and behavior]. Lôo H; Olié JP; Poirier MF; Amado I Ann Pharm Fr; 1998; 56(2):75-82. PubMed ID: 9770027 [TBL] [Abstract][Full Text] [Related]
6. [Predicted pharmacology of an antidepressant]. Pinder RM Encephale; 1981; 7(4 Suppl):371-80. PubMed ID: 7318755 [TBL] [Abstract][Full Text] [Related]
7. [The integration of behavior as a variable in psychopharmacological research]. Richelle M J Physiol (Paris); 1968; 60 Suppl 1():149-203. PubMed ID: 4951214 [TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961 [TBL] [Abstract][Full Text] [Related]
12. The chakragati mouse: a mouse model for rapid in vivo screening of antipsychotic drug candidates. Dawe GS; Ratty AK Biotechnol J; 2007 Nov; 2(11):1344-52. PubMed ID: 17886239 [TBL] [Abstract][Full Text] [Related]
13. Role of brain norepinephrine in the behavioral response to stress. Morilak DA; Barrera G; Echevarria DJ; Garcia AS; Hernandez A; Ma S; Petre CO Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec; 29(8):1214-24. PubMed ID: 16226365 [TBL] [Abstract][Full Text] [Related]
14. [Ethologic study of the sequelae of prenatal exposure to psychotropic agents]. Poshivalov VP; Kosenkova NS Farmakol Toksikol; 1989; 52(5):99-107. PubMed ID: 2689212 [TBL] [Abstract][Full Text] [Related]
15. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Korff S; Harvey BH Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714 [TBL] [Abstract][Full Text] [Related]
17. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Miczek KA; Fish EW; De Bold JF; De Almeida RM Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445 [TBL] [Abstract][Full Text] [Related]
19. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat. Kankaanpää A; Meririnne E; Seppälä T Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886 [TBL] [Abstract][Full Text] [Related]
20. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs? Obuchowicz E; Krysiak R; Herman ZS Neurosci Biobehav Rev; 2004 Oct; 28(6):595-610. PubMed ID: 15527865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]